Risk of non-melanoma skin cancer with thiopurine use in inflammatory bowel disease

被引：4
|
作者：
Subramaniam, Kavitha [1 ]
Pavli, Paul [1 ]
机构：
[1] Canberra Hosp, Gastroenterol & Hepatol Unit, Canberra, ACT, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2012年 / 27卷 / 02期
关键词：
ORGAN TRANSPLANT RECIPIENTS; AZATHIOPRINE; MELANOMA;
D O I：
10.1111/j.1440-1746.2011.07030.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
See article in J. Gastroenterol. Hepatol. 2012; 27: 385389.
引用
收藏
页码：193 / 194
页数：2
相关论文
共 50 条
  • [1] The Risk of a Second Non-Melanoma Skin Cancer With Thiopurine and Anti-TNF Use in Inflammatory Bowel Disease
    Scott, Frank
    Mamtani, Ronac
    Brensinger, Colleen
    Haynes, Kevin
    Chiesa-Fuxench, Zelma
    Zhang, Jie
    Chen, Lang
    Xie, Fenglong
    Margolis, David
    Curtis, Jeffrey
    Lewis, James
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S493 - S494
  • [2] Increased Risk for Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease
    Long, Millie D.
    Herfarth, Hans H.
    Pipkin, Clare A.
    Porter, Carol Q.
    Sandler, Robert S.
    Kappelman, Michael D.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (03) : 268 - 274
  • [3] Recurrence of Non-melanoma Skin Cancer in Inflammatory Bowel Disease Patients Who Continue Thiopurines After Developing Incident Non-melanoma Skin Cancer While on a Thiopurine
    Shah, Yash
    Trivedi, Chinmay
    Khan, Nabeel
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S327 - S327
  • [4] No Increased Risk of Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease Using Thiopurines
    van Schaik, Fiona D.
    Smeets, Hugo M.
    van der Heijden, Geert J.
    Siersema, Peter D.
    van Oijen, Martijn G.
    Oldenburg, Bas
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S770 - S771
  • [5] The risk of non-melanoma skin cancer in New Zealand in inflammatory bowel disease patients treated with thiopurines
    Bahi, Morwan
    Walmsley, Russell S.
    Gray, Andrew R.
    Young, David
    Hobbs, Catherine E.
    Aluzaite, Kristina
    Schultz, Michael
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (05) : 1047 - 1052
  • [6] Cumulative Risk of Non-Melanoma Skin Cancer in a Population-Based Cohort of Inflammatory Bowel Disease
    Yadav, Siddhant
    Harmsen, William
    Zinsmeister, Alan
    Tremaine, William
    Loftus, Edward
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S654 - S654
  • [7] SCREENING FOR MELANOMA AND NON-MELANOMA SKIN CANCER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AT A TERTIARY CARE HOSPITAL
    Tageldin, Omar
    Zelman, Sara
    Parsa, Nour A.
    Mansoor, Muhammad S.
    Batool, Asra
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S422 - S422
  • [8] Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: A cohort study
    Setshedi, Mashiko
    Epstein, David
    Winter, Trevor A.
    Myer, Landon
    Watermeyer, Gillian
    Hift, Richard
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (02) : 385 - 389
  • [9] Hydrochlorothiazide use and risk of non-melanoma skin cancer
    Chan, Chon-Wai Jeremy
    [J]. AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2024, 53 (05)
  • [10] Thiopurines and non-melanoma skin cancer: partners in crime in inflammatory bowel diseases
    Solitano, Virginia
    D'Amico, Ferdinando
    Correale, Carmen
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    [J]. BRITISH MEDICAL BULLETIN, 2020, 136 (01) : 107 - 117
12345